|
Status |
Public on Feb 23, 2016 |
Title |
K20 iPSC |
Sample type |
RNA |
|
|
Source name |
LRRK2 patient line #2 fibroblast
|
Organism |
Homo sapiens |
Characteristics |
diagnosis: Parkinsons disease cell type: Human skin fibroblast cell line: K20
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared with the Ambion MessageAmp kit for Illumina arrays
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
replicate 5
|
Data processing |
The data were normalised using quantile normalisation with IlluminaGUI in R
|
|
|
Submission date |
Feb 22, 2016 |
Last update date |
Feb 23, 2016 |
Contact name |
Ying Pei |
Organization name |
Buck Institute
|
Street address |
8001 redwood blvd
|
City |
novato |
State/province |
ca |
ZIP/Postal code |
94945 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (1) |
GSE78152 |
Derivation, characterization, and neuronal differentiation of integration-free induced pluripotent stem cell lines from Parkinsons disease patients carrying SNCA, LRRK2, PARK2, and GBA mutations |
|